Working… Menu

Phase IIa Study of the Product QGC001 Compared With Placebo in Patients With Essential Hypertension (2QG1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02322450
Recruitment Status : Completed
First Posted : December 23, 2014
Last Update Posted : September 28, 2016
Information provided by (Responsible Party):
Quantum Genomics SA